The job cuts are part of a restructuring plan to optimize its operating model and drive operational efficiencies, the company ...
Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health ...
On Feb. 18, 2026, investors weighed Kenvue's earnings momentum against looming merger costs and related risks.
Kenvue (NYSE: KVUE) reported fourth-quarter results yesterday that exceeded analyst expectations, with adjusted EPS of $0.27 ...
Zacks Investment Research on MSN
Kenvue (KVUE) beats Q4 earnings and revenue estimates
Kenvue (KVUE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.26 per share a year ago. These figures are ...
Feb 17 (Reuters) - Activist investor Starboard Value LP increased its stakes in cryptocurrency firm Riot Platforms and consumer health company Kenvue in the December quarter, while reducing ...
Shares of Kenvue Inc. KVUE slipped 1.17% to $18.66 Thursday, on what proved to be an all-around rough trading session for the ...
The FDA agreed to review Moderna’s seasonal flu shot after the vaccine maker said it would run extra tests in the elderly.
Kenvue Brands LLC agreed to pay $4.7 million to settle a Illinois Biometric Information Privacy Act class suit filed over its Neutrogena Skin360 app and website’s allegedly improper collection of ...
Kenvue (NYSE:KVUE) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-17. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
Drugmakers are urging the FDA to reassess the regulatory process of switching medications from prescription to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results